1. Schenone, M., et al., Target identification and mechanism of action in chemical biology and drug discovery. Nature chemical biology, 2013. 9(4): p. 232–240
2. Dimeloe, S., et al., T-cell metabolism governing activation,proliferation and differentiation; a modular view.Immunology, 2017. 150(1): p. 35–44
3. Ochocki, J.D. and M.C. Simon, Nutrient-sensing pathways and metabolic regulation in stem cells. The Journal of Cell Biology, 2013. 203(1): p. 23–33
4. Smith, R.A., et al., Mitochondrial pharmacology. TrendsPharmacological Sciences, 2012. 33(6): p. 341–52
5. Galluzzi, L., et al., Metabolic targets for cancer therapy.Nature Reviews Drug Discovery, 2013. 12: p. 829
6. Lee, J., Mitochondrial drug targets in neurodegenerative diseases. Bioorg Med Chem Lett, 2016. 26(3): p. 714-720
7. Wang, W., G. Karamanlidis, and R. Tian, Novel targets for mitochondrial medicine.Science Translational Medicine,2016. 8(326): p. 326rv3
8. Wills, L.P., et al., Assessment of ToxCast Phase II for Mitochondrial Liabilities Using a High-Throughput Respirometric Assay. Toxicol Sci, 2015. 146(2): p. 226-34
9. Sanuki, Y., et al., A rapid mitochondrial toxicity assay utilizing rapidly changing cell energy metabolism. The Journal of Toxicological Sciences, 2017. 42(3): p. 349–358
10. Divakaruni, A.S., et al., Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proceedings of the National Academy of Sciences, 2013. 110(14): p.5422–5427
11. Divakaruni, A.S., et al., Analysis and interpretation of microplate-based oxygen consumption and pH data. Methods Enzymol, 2014. 547: p. 309–354
12. Divakaruni, A.S., et al., Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis. Cell Metabolism, 2018. 28(3): p. 490–503.e7
13. Divakaruni, A.S., G.W. Rogers, and A.N. Murphy, Measuring Mitochondrial Function in Permeabilized Cells Using the Seahorse XF Analyzer or a Clark-Type Oxygen Electrode.Current protocols in toxicology, 2014.60: p. 25.2.1–25.2.16